A Study to Establish a Vascular Anomalies Tissue Repository
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-008171
Sponsor Protocol Number: 18-008171
About this study
The purpose of this study is to develop a resource (bank) of biospecimens and data collected from individuals with a vascular tumor or malformation to facilitate discovery and development of novel biomarkers for diagnosis and treatment of disease, better elucidate etiologic factors relating to vascular anomalies, and novel targeted therapeutic strategies for vascular anomalies.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Male or female patients, aged 0 to 100 with a vascular tumor or malformation.
- Able to provide Informed Consent (or parental ability to provide informed consent if under age 18).
- Have a Mayo Clinic Number.
Exclusion Criteria:
- Individuals who are unable to sign consent (e.g., mentally challenged, those declared legally incompetent, non-english speaking) or whose parents are unable to provide informed consent if under age 18.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Megha Tollefson, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available